Available to the public, the online edition of ACP Hospitalist includes features about clinical medicine, conference coverage, research news, success stories, and more.
bring together inpatient and outpatient clinicians to improve quality while reducing cost), but experts offered preliminary perspectives at the annual National Health Policy Conference on Feb.
Our coverage of the meeting includes a rundown of medical myths that are still commonly believed and relevant to hospital medicine. ... Other articles from our meeting coverage review overdose diagnosis and treatment and the latest on inflammatory bowel
Tissue plasminogen activator (tPA) was the star of the show at this yearâs International Stroke Conference 2009 in San Diego, with much discussion of expanding its treatment window and several studies ... New research presented at the conference
of it is how you account for revenue,” said William Jessee, MD, MGMA president and CEO, at a press conference.“ Non-hospital-owned practices count [revenue from] ancillaries, for example; ... primary care coverage and referrals in hospital- and
A feature article in this issue and some accompanying conference coverage focus on the obstacles to getting enough sleep while hospitalized. ... Our latest coverage is from the American Academy of Neurology. The subspecialists met here in Philadelphia in
Conference coverage from the American Academy of Neurology offers expert advice on prognostication for patients unconscious after cardiac arrest and rapid advances in stroke care.
Internists have been diagnosing patients for centuries, but two presentations at the Diagnostic Error in Medicine 11th International Conference, held in November 2018 in New Orleans, offered new approaches to the ... Primary Care in Boston, detailed the
Our July issue includes a cover story looking at new drugs and data on Clostridium difficile and extensive conference coverage of Hospital Medicine 2017. ... There's also conference coverage from Hospital Medicine 2017—onto patients, and avoiding
Despite challenges such as FDA regulation of research and uncertainties about potential risks of probiotics, the good bugs are becoming more prevalent in both consumer and health care settings.